Watch two leading experts in ED discuss the benefits and efficacy of Eroxon®
Throughout the development of Eroxon® there has been significant engagement with the ED medical community, and consultation with a range of leading experts in ED from Europe, and North and South America.
Watch a short video to find out what two leading experts in ED are saying about the benefits, features, and efficacy of Eroxon®.
Dr Wayne Hellstrom
Professor of Urology and Chief of Andrology, Tulane University School of Medicine, USA
Dr Sidney Glina
Professor of Urology and Head of Urology Department, Faculdade de Medicina do ABC, Brazil
David Ralph et al “MED3000, a clinically proven, fast-acting topical product for Erectile Dysfunction with the prospect of being the first globally available OTC treatment for ED” (MED3000 is the codename used when Eroxon® was in the research stage)